EZH2 and cancer: Based on our review of studies exploring these chromatin modifiers in various cancers and the established relationship between CREBBP mutations and EZH2 in SCLC73, we propose that loss-of-function mutations in chromatin modifiers (e.g., ARID1A, SMARCA4, UTX) lead to loss of NE identity and increased plasticity (Fig. 2).